Contrad Swiss Sa Is A Swiss Pharmaceutical Company Based In Luganospecializing In Regenerative Medicinefounded In 2011The Company Is Known For Its Innovative Therapeutic Solutions And Is The Owner Of The Proprietary Sigmolecs Technologythis Technology Enhances The Use Of Peptides As Active Ingredientsallowing For More Effective Therapies By Communicating With Cells In Their Own Language The Company Offers A Range Of Products And Servicesincluding Medical Devices Manufactured In Eu And Swiss Facilitiesaesthetic Products Like The Actv8Skn Line And Egyfil Lotionand Finished Dosage Forms Tailored To The Pharmaceutical Industryadditionallycontrad Swiss Has Developed The 500Linea Product Line Focused On Pain Managementwith A Dedicated Team Of About 13 Employeescontrad Swiss Aims To Deliver High Quality Solutions To Clients In The Premium Segment Of The Pharmaceutical Market
United Arab Emirates
Germany
